Back

Prognostic impact of chronic kidney disease and renal safety of contemporary therapies in patients with heart failure: a real-world analysis

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: When heart, kidney, and metabolism collide: risk and missed opportunities in care Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Paola Trapanese

Modena Polyclinic Modena University Hospital, Modena (Italy)

6 More presentations in this session

Presentation thumbnail
Persistent gender differences in the management of chronic kidney disease in patients with heart failure – follow-up of the InspeCKD study
Professor F. Mader (Erfurt-Altstadt, DE)
Abstract Slides Video
Presentation thumbnail
Stepwise intensification of guideline-directed medical therapy is associated with reduced major adverse kidney events in patients with HFpEF and diabetes
Doctor Y. Hoshika (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Association of cardiovascular-kidney-metabolic syndrome with cardiovascular mortality: a prospective cohort study in Madeira Island
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Bidirectional mendelian randomisation of kidney function and heart failure in african-ancestry populations
Doctor N. GAYE (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Chronic kidney disease in metabolic syndrome and heart failure: elevated risk, underutilized therapies, and missed opportunities for improved outcomes
Doctor D. Hochstein (Ramat Gan, IL)
Abstract Slides Video

Access the full session

Session thumbnail
When heart, kidney, and metabolism collide: risk and missed opportunities in care

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiorenal trade-off of sacubitril/valsartan in heart failure with reduced ejection fraction and advanced chronic kidney disease: a propensity-weighted multicentre analysis
31 August 2026
thumbnail
Congress Presentation
Renal function at discharge matters: graded prognostic impact of kidney dysfunction after decompensated heart failure with reduced ejection fraction
9 May 2026
thumbnail
Congress Presentation
Predictors and prognostic impact of chronic kidney disease in hospitalized patients with heart failure - insights from the cardiomining study
29 August 2025
thumbnail
Congress Presentation
How do we treat patients with chronic kidney disease stages 4-5 and heart failure with reduced left ventricular ejection fraction? Impact on 1-year mortality and hospital admissions
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources